Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Aplcc Poster Session 2 – Wednesday, November 28

Aplcc Poster Session 2 – Wednesday, November 28 APLCC/ITMIG 2012 Abstracts Volume 7, Number 11, Supplement 5, November 2012 POSTER SESSION 2 - CHEMOTHER APY 1 - November 28, 2012 14:05-14:55 APLCC POSTER SESSION 2 – P2-003: COMBINATION CHEMOTHERAPY OF NEDAPLATIN PLUS WEDNESDAY, NOVEMBER 28 DOCETAXEL IN PATIENTS WITH RECURRENT NON-SMALL-CELL LUNG CANCER AFTER COMPLETE RESECTION. POSTER SESSION 2 - CHEMOTHERAPY 1 - 1 1 1 1 1 Yo Kawaguchi , Keiko Ishida , Keiko Ueda , Keigo Okamoto , Ryosuke Kaku , Masayuki 1 1 1 1 1 November 28, 2012 14:05-14:55 Hashimoto , Shoji Kitamura , Koji Teramoto , Jun Hanaoka , Noriaki Tezuka , Shoji Asakura 1 2 Department Of Surgery, Shiga University Of Medical Science, Otsu/JAPAN, General POSTER SESSION 2 - CHEMOTHER APY 1 - November 28, 2012 14:05-14:55 Thoracic Surgery, Kohka Public Hospital, Kohka-city/JAPAN P2-001: A FEASIBILITY STUDY OF SPLIT-DOSE CISPLATIN AND VINORELBINE AS ADJUVANT CHEMOTHERAPY FOR COM- Background: In advanced non-small-cell lung cancer (NSCLC), the cisplatin-based PLETELY RESECTED NON-SMALL CELL LUNG CANCER chemotherapy should be included in the standard protocols of cancer treatment. This strategy may be often applied for the treatment for patients with recurrent NSCLC after Fumihiko Hirai, Ryou Toyozawa, Eiko Inamasu, Miyako Kojo, Gouji Toyokawa, complete resection. Patients http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Aplcc Poster Session 2 – Wednesday, November 28

Journal of Thoracic Oncology , Volume 7 – Nov 1, 2012

Loading next page...
 
/lp/wolters-kluwer-health/aplcc-poster-session-2-ndash-wednesday-november-28-Zms2IGUbAh

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1556-0864

Abstract

APLCC/ITMIG 2012 Abstracts Volume 7, Number 11, Supplement 5, November 2012 POSTER SESSION 2 - CHEMOTHER APY 1 - November 28, 2012 14:05-14:55 APLCC POSTER SESSION 2 – P2-003: COMBINATION CHEMOTHERAPY OF NEDAPLATIN PLUS WEDNESDAY, NOVEMBER 28 DOCETAXEL IN PATIENTS WITH RECURRENT NON-SMALL-CELL LUNG CANCER AFTER COMPLETE RESECTION. POSTER SESSION 2 - CHEMOTHERAPY 1 - 1 1 1 1 1 Yo Kawaguchi , Keiko Ishida , Keiko Ueda , Keigo Okamoto , Ryosuke Kaku , Masayuki 1 1 1 1 1 November 28, 2012 14:05-14:55 Hashimoto , Shoji Kitamura , Koji Teramoto , Jun Hanaoka , Noriaki Tezuka , Shoji Asakura 1 2 Department Of Surgery, Shiga University Of Medical Science, Otsu/JAPAN, General POSTER SESSION 2 - CHEMOTHER APY 1 - November 28, 2012 14:05-14:55 Thoracic Surgery, Kohka Public Hospital, Kohka-city/JAPAN P2-001: A FEASIBILITY STUDY OF SPLIT-DOSE CISPLATIN AND VINORELBINE AS ADJUVANT CHEMOTHERAPY FOR COM- Background: In advanced non-small-cell lung cancer (NSCLC), the cisplatin-based PLETELY RESECTED NON-SMALL CELL LUNG CANCER chemotherapy should be included in the standard protocols of cancer treatment. This strategy may be often applied for the treatment for patients with recurrent NSCLC after Fumihiko Hirai, Ryou Toyozawa, Eiko Inamasu, Miyako Kojo, Gouji Toyokawa, complete resection. Patients

Journal

Journal of Thoracic OncologyWolters Kluwer Health

Published: Nov 1, 2012

There are no references for this article.